Researchers in Manchester have investigated a patient-centred approach to assessing the side effects of radiotherapy and have shown that it may be able to improve the detection and management of treatment-related toxicity.
For lung cancer that cannot be removed with surgery, radiotherapy is the primary treatment option. However, it is associated with a range of side effects, including fatigue and inflammation of the oesophagus and lungs.
Current methods to record treatment-related toxicities rely on assessment by health care professionals. Now a team from The University of Manchester and The Christie NHS Foundation Trust